BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3987214)

  • 1. Management of maldigestion associated with pancreatic insufficiency.
    Perry RS; Gallagher J
    Clin Pharm; 1985; 4(2):161-9. PubMed ID: 3987214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment.
    Bruno MJ; Haverkort EB; Tytgat GN; van Leeuwen DJ
    Am J Gastroenterol; 1995 Sep; 90(9):1383-93. PubMed ID: 7661155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic exocrine insufficiency: diagnostic evaluation and replacement therapy with pancreatic enzymes.
    Hammer HF
    Dig Dis; 2010; 28(2):339-43. PubMed ID: 20814209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic pancreatitis. Focus on enzyme replacement therapy.
    Dobrilla G
    Int J Pancreatol; 1989; 5 Suppl():17-29. PubMed ID: 2702247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
    Littlewood JM; Wolfe SP; Conway SP
    Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic pancreatitis and maldigestion.
    Petersen JM; Forsmark CE
    Semin Gastrointest Dis; 2002 Oct; 13(4):191-9. PubMed ID: 12462705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Croatian guidelines for the management of pancreatic exocrine insufficiency].
    Rustemović N; Krznarić Z; Bender DV; Ostojić R; Cavka SC; Milić S; Anić B; Ljubicić N; Mesarić J; Stimac D; ; ; ; ;
    Lijec Vjesn; 2012; 134(5-6):141-7. PubMed ID: 22930931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maldigestion from pancreatic exocrine insufficiency.
    Pongprasobchai S
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():99-102. PubMed ID: 24251713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of pancreatic insufficiency].
    Ansaldi N; Santini B; Garbagni C
    Pediatr Med Chir; 1983; 5(4):149-55. PubMed ID: 6557569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
    Santini B; Ivaldi AP
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.
    Laiho KM; Gavin J; Murphy JL; Connett GJ; Wootton SA
    Clin Nutr; 2004 Jun; 23(3):347-53. PubMed ID: 15158298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic enzyme replacement therapy in post-pancreatectomy patients.
    Braga M; Cristallo M; De Franchis R; Mangiagalli A; Zerbi A; Agape D; Primignani M; Di Carlo V
    Int J Pancreatol; 1989; 5 Suppl():37-44. PubMed ID: 2702249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.